One woman’s trial against consumer health care giant Johnson & Johnson alleging cancer risks with the company’s talc-containing products was named the most impressive plaintiff verdict in 2017 by Courtroom View Network (CVN), a news organization that webcasts high-stakes civil trials.
The news organization covered a variety of litigation to compile its Top 10 list, including bellwether product liability trials, medical malpractice trials, and complex commercial trials. The verdicts were not ranked solely by amount awarded. The news group also took into consideration the facts of each case, the parties and attorneys involved, and the potential broader impact of the verdict.
The No. 1 plaintiff verdict involved the case of Eva Echeverria, who took Johnson & Johnson to court in July over claims the company’s talcum powder products caused her to develop ovarian caner. A Los Angeles, California jury awarded her a headline-grabbing $417 million, one of the largest plaintiffs verdicts awarded in the U.S. in 2017.
Echeverria’s verdict came after juries in St. Louis, Missouri had awarded verdicts totaling more than $300 million in similar cases brought by women who blamed Johnson’s Baby Powder and Shower to Shower for their ovarian cancer.
Beasley Allen attorney David Dearing was part of the trial team representing Echeveria. Others included Allen Smith with the Smith Law Firm, Mark Robinson and Scot Wilson with Robinson Calcagnie, and Michelle Parfitt with Ashcraft & Gerel LLP.
Though Johnson & Johnson was since granted its motion for a new trial – which the plaintiffs have appealed – the outcome of this trial still garnered the No. 1 spot on CVN’s Top 10 Most Impressive Plaintiff Verdicts for 2017.